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POLYMERIC CONSTRUCTS TOWARDS TISSUE ENGINEERING 
SUMMARY 
Biodegradable polymeric constructs for bone tissue engineering, are 3D structures 
that allow bone cells to attach and reproduce over them. Because of biodegradability 
properties, they are not permanent in the body and degrade slowly while bone cells 
are reproducing. Thus, bone cells replace scaffold in time meaning healing of defect 
sides. 
Bone cells are natural living composites whose 60% is composed of mineral, mainly 
hydroxyapatite. In the bone biomineralization process, hydroxyapatite minerals are 
crosslinked by type I collagens to form highly rigid and relatively flexible bone 
structure. In this project, it was tried to mimic bone biomineralization process by 
crosslinking hydroxyapatite with poly(N-vinyl-2-pyrrolidone-co-maleic acid), a 
biodegradable, biocompatible and highly hydrophilic copolymer having reactive 
groups to couple with many chemical compounds like hydroxyapatite. Also, 
hydroxyapatite was crosslinked with poly(N-vinyl-2-pyrrolidone) for comparison.  
The study consists of three steps: Synthesis of composites, scaffolding and 
transplantation to rats. 
In order to synthesize composites, firstly poly(N-vinyl-2-pyrrolidone-co-maleic 
anhydride) was synthesized by free radical copolymerization of N-vinyl-2-
pyrrolidone with maleic anhydride. The resulted polyanhydride was hydrolyzed in 
order to obtain poly(N-vinyl-2-pyrrolidone-co-maleic acid). Then, hydroxyapatite 
was crosslinked with poly(N-vinyl-2-pyrrolidone-co-maleic acid) and with poly(N-
vinyl-2-pyrrolidone) by two methods. Either hydroxyapatite was synthesized 
separately then crosslinked with the polymers or hydroxyapatite was synthesized 
over the polymers. All the composite synthesis reactions were carried out at several 
polymers to hydroxyapatite weight ratios. The synthesis of the composites was 
confirmed with FT-IR, XRD and fluorescence microscopy analyses. FT-IR 
spectroscopy provided information about chemical binding mechanism while XRD 
identified crystallinity, and optic properties of the composites were studied with 
fluorescence microscopy.  It was detected that PVP has lower binding tendency to 
hydroxyapatite than poly(N-vinyl-2-pyrrolidone-co-maleic acid). 
Among several scaffolding methods tested, wet molding method was chosen and 
optimized as slush molding/particulate leaching method. Scaffolds were fabricated 
without using organic solvents. The resulted scaffolds were very strong and highly 
hydrophilic. 
The optimized scaffolds were transplanted to rats at Sisli Etfal Hospital. 4 types of 
sample and one type control were transplanted to rats at anterior femur which was 
defected before. Each sample was transplanted to seven rats. Healing process of the 
rats is being investigated. It is planned to make the final examination on the rats in 
2008 September. 
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DOKU MÜHENDİSLİĞİNE YÖNELİK POLİMERİK YAPILAR 
ÖZET 
Kemik doku mühendisliğine yönelik biyoyıkılabilir polimerik yapılar kemik 
hücrelerinin tutunup üzerinde çoğalabildikleri 3 boyutlu porlu yapılardır. Biyoyıkılır 
olduklarından, bedende sürekli kalmazlar ve zamanla yıkıldıkça kemik hücreleri 
çoğalarak yıkılan iskeletin yerine geçerler. Böylece, bir sure sonra, biyoyıkılır yapı 
tamamen yıkılmış ve yerini kemik hücrelerine bırakmış olacaktır ki bu da kemik 
dokusunun iyileşmesi anlamına gelir. 
Kemik hücreleri ağırlığının %60’ı mineral olan doğal canlı kompozit hücrelerdir. Bu 
mineral yapının büyük bir kısmı hidroksiapatit mineralidir. Kemik 
biyomineralleşmesinde hidroksiapatitler tip 1 kollajenlerle çapraz bağlanarak 
oldukça sağlam ve görece esnek kemik yapısını oluştururlar. Bu çalışmada, 
biyoyıkılır, biyouyumlu ve oldukça hidrofilik olup üzerinde diğer kimyasal 
bileşiklerle ve hidroksiapatitle bağlanabilecek grupları bulunan bir polimer olan 
poli(N-vinil-2-pirolidon-ko-maleik asit) ile hidroksiapatiti çapraz bağlayıp kemik 
biyomineralleşmesi taklit edilmeye çalışıldı. Aynı zamanda karşılaştırma amacıyla 
hidroksiapatiti poli(N-vinil-2-pirolidon) ile de çapraz bağlandı. 
Çalışma 3 aşamadan oluşmaktadır: Kompozitlerin sentezi, iskelet yapı oluşturma ve 
iskelet yapıların sıçanlara aktarımı. 
Kompozitlerin sentezi için, ilk once serbest radikal polimerizasyonu ile poli(N-vinil-
2-pirolidon-ko-maleik anhidrit) sentezlendi. Daha sonra bu polianhidrit yapı suda 
hidroliz edilerek poli(N-vinil-2-pirolidon-ko-maleik asit) elde edildi. Daha sonra 
hidroksiapatit, poli(N-vinil-2-pirolidon-ko-maleik asit) ve poli(N-vinil-2-pirolidon) 
ile 2 farklı yöntemle çapraz bağlandı. Çapraz bağlanma hidroksiapatitin farklı 
ortamda sentezlenip daha sonra polimer çözeltisine eklenmesi ya da polimerlerin 
bulunduğu ortamda hidroksiapatitin sentezlenmesi ile yapıldı. Kompozit sentez 
reaksiyonları farklı polimer:hidroksiapatit ağırlık oranlarında yapıldı. Kompozitlerin 
sentezi FT-IR, XRD ve floresans mikroskobu ölçümleri ile onaylandı. FT-IR 
spektroskopisi kompozitlerin kimyasal bağlanma mekanizması ile ilgili bilgi verirken 
XRD ile kristalliği ve floresans mikroskobu ile çeşitli optik özellikleri hakkında 
bilgiler edinildi. Analizler poli(N-vinil-2-pirolidon)’un hidroksiapatite ilgisinin, 
poli(N-vinil-2-pirolidon-ko-maleik asit)’in hidroksiapatite ilgisinden daha düşük 
olduğunu gösterdi. 
Çeşitli iskeletleme yöntemleri denenip, çamur kalıplama/parçacık süzme yöntemi 
kompozitlere yönelik geliştirildi. İskeletleme sürecinde hiçbir organik çözücü 
kullanılmamıştır ve oldukça hidrofilik ve sağlam iskeletler üretilmiştir. 
İyileştirilmesi yapılmış iskeletler Şişli Etfal Hastahanesinde sıçanlara aktarılmıştır. 4 
çeşit örnek ve bir de kontrol çeşidi, kalça kemiğinin ön kısmında zedelendirilme 
oluşturulmuş sıçanlara aktarılmıştır. Her bir çeşit örnek için yedişer sıçana aktarım 
yapılmış olup iyileşme süreci izlenmektedir. Sıçanlar üzerinde son kontrolün 
Eylül 2008’de yapılması planlanmaktadır. 
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1. INTRODUCTION AND AIM 
Advances in bone tissue engineering have increased the importances of polymeric 
scaffolds. Polymeric scaffolds are three-dimensional macroporous structures that 
facilitate cell attachment, migration and differentation. A ideal scaffold for bone 
tissue engineering also must have similar properties such as mechanical and tensile 
strength, etc, with bone structure and be biodegradable and biocompable.  
It is known that hydroxyapatite has high biocompability and high tensile strength, but 
low elasticity modulus, low hydrophilicity and low osteoinductibility, so that several 
polymers have been chemically conjugated to hydroxyapatite to make perfect 
scaffold for bone tissue engineering. 
Poly(N-vinyl-2-pyrrolidone) and poly(N-vinyl-2-pyrrolidone-co-maleic acid) are 
biocompatible polymers that have chemical groups to react with hydroxyapatite. 
Furthermore, highly water solubility and biodegradability properties of these 
polymers may enable us to construct biodegradable and more hydrophilic scaffolds.  
In this work, we aimed to mimic bone mineralogy by conjugating hydroxyapatite 
with biocompatible and biodegradable vinylpyrrolidone homo and copolymers which 
is water soluble, highly hydrophilic and rich in functional groups to chelate with 
calcium. 
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2. THEORETICAL PART 
2.1. Bone Tissue Engineering 
Tissue engineering is a multidisciplinary science using chemical, biological and 
engineering methods to heal or replace living tissues (Laurencin et al., 1999).  Bone 
tissue engineering is the novel branch of tissue engineering aiming to heal bone 
defects (Lu et al., 2003).  
Bone is a living composite material containing 10% water, 30% matrix and 60% 
mineral by weight. The most abundant mineral is hydroxyapatite. Hydroxyapatite is a 
calcium phosphate derivative that is in the form of Ca10(PO4)6(OH)2. The mineral 
component gives comprensive strength to bone. The matrix component of bone is 
mainly composed of type I collagen in association with hydroxyapatite. Bone matrix 
gives tensile strength to bone (Athanasiou et al., 2000). 
The main function of bone is to carry the weight of the body by providing 
mechanical support to body. Also, bone provides an anchor for muscles to make 
motion. Bone tissue is composed majorly of four types of cells. While osteocytes are 
found in the interior of bone tissue, bone lining cells, osteoblasts and osteoclasts are 
found on the bone surface.  
Bone tissue is a dynamic tissue that cell birth and cell death occur in parallel.  
Osteoblasts are mononucleate cells that arise from osteoprogenitor cells and 
responsible for new bone cell generation. They are found on the surface of bone 
tissue and excrete collagen and other compounds of bone cells in a Golgi complex to 
produce osteocytes or bone lining cells. 
Osteoclasts are multinucleate cells that are responsible for cell resorption. They are 
found on Howship's lacunae site of the surface of bone tissue and function by 
removing mineralized matrix of bone tissue. They cytoplasm has high amount of 
mitochondria, vacuoles and lysosomal vesicles to resorb mineralized matrix of bone 
tissue. 
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Osteocytes are mononucleate cells that are found in the interior of bone tissue. They 
are the most abundant cell type of bone tissue. They are able to excrete collagen and 
possess lysosomal vesicles to digest bone cells (Baron, 2006; Sandy, et al., 1996) 
Bone tissue has ability of regeneration. The healing of damaged bone occurs in three 
stages. The inflammation stage starts when bone tissue is damaged. Macrophages go 
to the wound site and digest the damaged bone cells. In the repair stage, osteoblasts 
produce bone matrix and a callus. In the remodeling stage, resorption and deposition 
proccesses occur together to remodel the bone tissue. Osteoclasts digest old cells and 
make a empty tunnel which is then invaded by a blood vessel and osteoblasts which 
produces osteocytes (Hulth et al., 1989; Yaszemski et al., 1996) . 
There are several approaches to heal bone defects 
Xenografting is a method based on transplanting animal tissues to patients. 
However, there is a high risk of immune rejection. Also, this method brings infection 
risk to patient. 
Allografting method uses tissue of another person to heal patients. Although 
immune rejection risk is lower than xenografting method, finding compatible donor 
is problem because of immune rejection risk. Also, the application is expensive, 
painful and brings infection risk to patients (Stevenson, 1999). 
Autografting method is transplanting a tissue from some part of body to another part 
of the same patient. Although this method doesn’t have risk of immune rejection, it is 
expensive, very painful and brings infection risk to patients too. Also, it requires 
second operation on the same patient (Lancer and Vacanti, 1993; Laurencin et al., 
1999). 
In order to cope with the limitations of these methods, new biomaterials are being 
developed to heal bone defects. Several metals, polymers and ceramics have been 
used. However, none of them is enough on their own. For example, bone cement, 
copper and silver have low bioconductivity (Albrektsson and Johansson, 2001).  
Thus, the novel approach is to use scaffolds to repair bone defects. 
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2.2. Scaffolds in Bone Tissue Engineering 
Bone tissue engineering scaffolds are 3 dimensional porous structures over which 
bone cells settle down and reproduce. An ideal scaffold for tissue engineering should 
be porous in order to allow matter exchange, biocompatible, biodegradable, and 
osteoconductive (Laurencin et al., 1999). Also, an ideal scaffold should be 
osteoinductive and allow osteointegration. 
Biodegradable scaffolds break down into smaller compounds by the time so that they 
functions until degradation. They are replaced by bone cells during biodegradation, 
so that they are not persistent like metal implants. 
Biocompability is a property of ideal scaffolds that doesn’t trigger a negative host 
response. 
Osteoconductive scaffolds provide appropriate area over which bone cells 
regenerate. 
Osteoinductive scaffolds trigger osteogenesis so it is crucial for bone tissue healing. 
Osteointegration is the anchorage of bone cells at the bone to scaffold contact 
(Albrektsson and Johansson, 2001). 
In order to construct scaffold with these properties, several biodegradable polymers 
are used in the structure of scaffolds. Some polymers have reactive groups so that a 
drug delivery system can be integrated on them. For example, a growth factor or a 
signal for osteogenesis can be conjugated (Saito et. al., 2005). 
2.2.1. Scaffolding methods in bone tissue engineering 
The most widely used scaffolding methods are solvent casting/particulate leaching, 
gas foaming, phase separation/emulsification, and polymerization under light 
methods. 
2.2.1.1. Solvent casting/particulate leaching method 
In this method, a porogen is used to make pores. The most widely used porogen is 
grinded NaCl. A liquid mixture of composite is poured into molds containing 
porogen and left under heat to remove the solvent. Then, the solid composite is 
inserted into a solution that can solve the porogen but not the composite. Then, 
porogen passes to the solution and leaves pores at the composite. Porogen is very 
 5   
important in this method. The diameter of porogen defines the diameter of pores 
while the amount of porogen defines the rate of porosity. Also, solubility of porogen 
in different solutions is very important. For example, if NaCl is used as porogen, 
water is used to remove NaCl. If hydrocarbons are used as porogens, organic 
solutions are used to remove porogens. After the formation of porous scaffold, 
organic solvents are removed by freeze drying or heating under vacuum. 
2.2.1.2. Gas foaming method 
This method uses gases to make pores. Grinded dry composites are compression 
molded above glass transition temperature of polymer and the resulted nonporous 
scaffold is exposed to CO2 under high pressure for several days. Then, the applied 
CO2 gas was removed suddenly to make pores. This method doesn’t need leaching 
step and organic solvents, but usually unconnected pores are obtained and high 
temperatures while compression step prevents using some polymers. 
Gas foaming method can also be connected with particulate leaching method. A 
sublimable porogen is added to liquid composite mixture and poured into molds. 
Later, the composite is dried and dipped into water to let the porogen sublime. This 
method allows constructing porous scaffolds with interconnected pores (Micos and 
Temenoff, 2000). 
2.2.1.3. Phase separation/emulsification method 
This process uses emulsion to make pores. First of all, composite solution in organic 
solvent is mixed with water to make emulsion. Then, the emulsion is poured into a 
mold to give shape. After the emulsion is dried under vacuum or freeze drying, 
porous scaffold is formed. The rate of pores can be setup by changing water content 
and viscosity of the emulsion. Since organic solvents are needed to make emulsion, 
this method requires vacuum drying or freeze drying for a long time to remove 
organic solvents (Antonios and Johnna, 2000). 
2.2.1.4. Polymerization under UV method 
In this method, monomer solution including fotoinitiator is poured into a mold and 
then polymerized by the light. In order to increase biocompability, firstly, monomers 
are reacted with several compounds such as hydroxyapatite, and then 
photo-polymerized under light. Very strong scaffolds can be constructed with this 
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method but it needs freeze drying or vacuum drying to remove remaining nonreacted 
monomers (Tsang and Bhatia, 2004).  
2.2.2. Biological characterization of scaffolds 
The fabricated scaffolds are tested with several assays and transplanted to animals to 
see the results in vivo. 
2.2.2.1. In vitro assays 
Bone stem cells are cultured on scaffolds to test biocompability, osteoconductivity 
and osteoinductivity properties of the scaffold. In vitro cell viability and cell 
proliferation measurements over scaffolds give impression about the compability of 
the scaffolds. In order to measure cell viability and cell proliferation, several 
methods have been developed. 
MTT assay 
MTT assay is a method to measure cell viability. The principle of the assay is the 
reduction of tetrazolium salts to colored formazons by metabolically active cells. 
MTT is a yellow tetrazolium whose chemical name is 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide. MTT is reduced to insoluble purple formazan by 
mitochondrial enzymes of living cells. After dissolving of the purple formazan, 
absorbance is measured by a spectrophotometer. The absorbance is proportional to 
cell viability. Thus, the higher the absorbance is, the higher the cell viability is on the 
scaffold (Mosmann, 1983 ; Wilson, 2000). 
Nitric Oxide Assay 
This assay is based on measuring nitrite (NO2-) which is an oxidation product of 
nitric oxide (NO). Nitric oxide is a host defense initiator found at mammalian cells. 
In the other words, NO content is a measure of cytotoxicity. Since NO is very 
volatile, it is much difficult to measure direct NO concentration. Also, most of the 
NO is oxidized to nitrate (NO3-) and nitrite (NO2-). Thus, sum of nitrate and nitrite 
concentrations gives the approximate NO concentration. 
In NO assay, nitrate is converted to nitrite by nitrate reductase enzyme and then 
nitrite concentration is determined as a measure of NO content of cells. There are 
many kits to determine nitrite concentration. One of them is based on Griess 
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Reaction. In Griess Reaction, nitrite is reacted with sulfanilic acid to obtain 
diazonium ion. Then, the diazonium ion is reacted with N-(1-naphthyl) 
ethylenediamine to produce a coloured azo-derivative whose absorbance is a 
measure of total nitrite concentration (Miles et al. 1996). 
Sircol Assay 
Sircol assay is a method to measure acid soluble collagens of mammalian cells.  With 
Sircol assay, total collagen in the cell and collagen released to the culture media can 
be measured.  
Sircol assay is based on the reaction of sulphanic acid side chains of Sirius Red dye 
with basic amino acids of collagen. This precipitate is purified from free dye and the 
absorbance is measured after dissolution of the precipitate. Since the matrix 
component of bone is mainly composed of type 1 collagen, total collagen content is a 
measure of cell proliferation (Biocolor).  
Alkaline Phosphatase Assay  
Alkaline phosphatase assay is based on hydrolysis of p-nitrophenylphosphate (p-
NPP) to yellow coloured p-nitrophenol (p-NP) by alkaline phosphatase in alkaline 
pH. Then, the absorbance of p-nitrophenol is measured at 405 nm and 37oC. 
Alkaline phosphatase enzyme is found at the surface of osteoblasts. Alkaline 
phosphatase functions in removing phosphate group (dephosphorylation) causing a 
local alkaline pH. The increase in the pH causes calcium ions to crystallize which is 
needed for biomineralization process.  Thus, growing bone cells produce more 
alkaline phosphatase than non-growing bone cells. Therefore, the amount of alkaline 
phosphatase produced by the cell over a scaffold is a measure of bioinductivity 
(Bessey et al., 1946). 
2.2.2.2. Transplantation of scaffolds 
The aim of scaffold production is to heal bone defects in bone tissue engineering.  
There are two approaches to heal bone defects. 
First of all, bone cells can be regenerated in vitro on scaffolds and then transplanted 
to patients. Because of their high regenerative potentials, stem cells are preferred for 
this approach. Bone stem cells are supplied with growth factors and culture media 
and grown on the scaffold. After several days, the formed tissue is ready to be 
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transplanted at the same shape with the scaffold. Although this approach fastens the 
healing of the defect, it requires stem cell isolation from the patient and preculturing 
of the stem cells. In this approach, the mechanical properties of the scaffolds are not 
very important because it gets close mechanical properties with the bone after the 
cell regeneration on the scaffold. 
Another approach is transplanting the scaffold directly to the patient without 
preculturing with stem cells. If the defect site of the bone loads pressure of the body, 
scaffolds with high mechanical properties must be chosen. Thus, this approach 
usually requires convenient scaffold with close mechanical properties with bone 
(Engel, et al., 2008).  
2.3. Biodegradable Polymers 
Biodegradable polymers are polymers that can be broken down into smaller 
non-toxic compounds. Completely biodegradable polymers are able to degrade into 
CH4, CO2, H2O, H2 or N2. There are two types of biodegradation. In surface-eroding 
systems, biodegradation occurs at surface of the polymers such as polyanhydrides 
and polyorthoesters. Thus, the rate of biodegradation is proportional to surface area 
of the scaffold. In bulk hydrolysis systems, biodegradation occurs uniformly.  
Biodegradable polymers have crucial importance in the life because autotrophs, 
primary producers, store the energy in the chemical bonds of biodegradable 
polymers. Then, they and other organisms use this energy by breaking down the 
biodegradable polymers. Also, because of their chemical properties and ability to be 
recycling, organisms produce and use biodegradable polymers in whole the structure 
of cells. Lipid, polysaccharide, polyamides and polyester derivatives are the most 
widely used polymers in the life. 
Degradation of the polymers can be non-biological (spontaneous) or biological. 
Non-biological degradation occurs over hydrolysis of functional groups of the 
polymers. One of the examples to spontaneously degradable polymers is polyesters. 
Polyesters are chemical compounds that have at least one “–COOR” group either at 
main chains (Figure 2.1a) or at side chains (Figure 2.1b).  
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Figure 2.1 : Chemical Structures of Polyesters a: Poly(3-hydroxy butyrate) has ester bonds 
at the main chain, b: Polyvinyl acetate has ester bonds at the side chain 
 
Ester groups hydrolyze in acidic or basic aqueous conditions so that polyesters 
degrade into monomeric units in the water. Thus, it is possible to construct a 
biodegradable scaffold based on polyesters. The degradation rate is proportional to 
the hydrophilicity and surface area of the polyester.  
Biological degradation is done by enzymes or by-products (acids or bases) secreted 
by cells (Anderson et al, 1993; Whitney et al, 1993). Biological degradation occurs 
in two steps. In the first step, biodegradable polymeric chains are cleaved by 
enzymes. This process occurs usually outside the cell. Big polymeric chains are 
divided into small fragments by extracellular enzymes. In the second step, smaller 
fragments are taken into the cell and further digested into much smaller molecules. 
This step provides much more energy than the first step. Biodegradation is very 
important in the life because it provides energy to cells. 
Biological degradation by micro-organisms can be done by enzymic hydrolysis or 
enzymic oxidation. The functional group of biodegradable polymers firstly 
hydrolyzed and/or oxidized to carboxylic acids and then enters β-oxidation pathway 
for complete biodegradation (Zee, 2005). 
Enzymic Hydrolysis 
Proteases, esterases and glycoside hydrolases are responsible for hydrolysis of 
biodegradable polymers containing glycosidic, peptide and ester bonds. 
Proteases hydrolyse peptide (amide) bonds of polyamides. They are categorized 
according to catalytic groups. Serine proteases have serine amino acid in their active 
site while cysteine proteases have cysteine, metal containing proteases have metal 
and aspartic proteases have aspartic acid as their catalytic groups (Whitaker, 1995). 
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Esterases are responsible for hydrolysis of ester bonds of polyesters. They are 
subdivided into five groups according to ester groups they hydrolyse: Carboxylic 
ester hydrolases, thiol ester hydrolases, phosphoric monoester hydrolases, phosphoric 
diester hydrolases, and sulfuric ester hydrolases. Lipases are a famous kind of 
carboxylic esterases and hydrolyse the lipids (Schirmer, 1995). 
Glycosidases hydrolyse glycosidic bonds of polysaccharides. Amylases and 
cellulases are important kinds of glycosidases. Amylases degrade starch and starch 
derivative polymers by hydrolysing α-1,4-glycoside linkages, while cellulases 
degrade cellulose and cellulose derivative polymers by hydrolysing β-1,4-glycoside 
linkages (Ratledge, 1992 ; Antranikian, 1992).  
Enzymic Oxidation 
Oxidoreductases are responsible for enzymic oxidation of biodegradable polymers. 
There seven type of enzymic oxidation listed in table 2.1. 
Table 2.1. Biodegradation Reactions of Oxidoreductases 
Reaction Type Reaction Formula 
1 AH2  +  B  ===>  A  +  BH2 
2 AH2  +  O2  ===>  A  +  H2O2 
3 AH2  +  ½ O2  ===>  A  +  H2O 
4 AH2  +  H2O  +  B  ===>  AO  +  BH2 
5 A  +  H2O2  ===>  AO  +  H2O 
6 A  +  O2  +  BH2  ===>  AO  +  B  +  H2O 
7 A  +  O2  ===>  AO2 
 
The most common oxidoreductases catalyse type 1 reactions. In this reaction, the 
substrate (A) is oxidized by removal of hydrogens with introduction of an electron 
acceptor (B), such as NAD+ and NADP+. Oxidoreductases catalysing type 2 and type 
3 reactions use molecular oxygen as electron acceptor to remove hydrogen from the 
substrate. Types 4 to type 7 reactions involve incorporation of oxygen atoms into the 
substrate. Oxygen source can be H2O (type 4 reaction), H2O2 (type 5 reaction) or 
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molecular oxygene (type 6 and type 7 reactions). Oxygenases use molecular oxygen 
as oxygen source and are divided into 2 clases. Monooxygenases catalyse type 6 
reactions, introducing single oxygen atom into the substrate, while dioxygenases 
introduce molecular oxygen into the substrate (type 7 reaction). 
Biodegradable polymers are very appropriate for scaffold fabrication because they 
are not persistent in the body. As the scaffolds degraded, living tissue can take the 
place of the scaffold. Thus, biodegradable scaffolds offer completely healing of the 
defected tissue. Moreover, biodegradation permits controlled drug release. When a 
drug is conjugated, as the scaffold degrades, it releases the drug slowly. Thus, a 
growth inducing signal can be introduced into scaffolds to release it slowly. Finally, 
the biodegradation rate depends on pH, physical factors, bonded drugs or groups, 
chemical structure such as functional groups and repeating units of polymers. Thus, 
changing these parameters allow fabricating scaffolds with optimized biodegradation 
rate (Zee, 2005).  
2.3.1. Widely used polymers in tissue engineering 
PLA (polylactide), PGA (polyglycolide) and PLGA [poly(lactide-co-glycolide)] are 
the most widely used polymers in tissue engineering (Figure 2.2). They are 
polyesters having spontaneous biodegradability properties in aqueous environments. 
                
Figure 2.2 : Chemical Structures of PLA, PGA and PLGA 
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Their ester bonds give hydrolysis reactions in aqueous environments, so they are 
degraded into their components (lactic acid and glycolic acid) which are used by 
body (2.1). Thus, these polymers are biodegradable. (Atala et al., 1997) 
 
(2.1) 
 
Although all the PLA, PGA and PLGA polymers are relatively hydrophobic 
polymers, poly(lactic acid) has one more methyl group making it more hydrophobic. 
Thus, hydrolysis and biodegradation rates of PLA are slower than those of PGA and 
PLGA. 
Because of shorter chain, PGA has higher melting point and lower solubility in 
organic solvents (Atala et al., 1997). Also PGA is insoluble in dioxane and 
chloroform. Thus, it is more difficult to process PGA for constructing a scaffold. 
Thus, PLA and PLGA polymers are preferred more than PGA.  
However, all of these esters release acidic hydrolysis products which trigger 
inflammatory reactions at some patients (Lanza et al., 1997). Thus, polycaprolactone 
(Figure 2.3), biodegradable polyester, has been tried as scaffold in bone tissue 
engineering (Atala et. al., 1997). 
 
 
Figure 2.3 : Chemical Structure of Poly(ε-caprolactone) 
 
As seen in figure 2.3, PCL has more methyl groups than PGA. Thus, the 
biodegradation rate is much slower than PGA allowing it to be used as longer term 
implants. Furthermore, much slower hydrolysis reaction allows its weak acidic 
hydrolysis products to be tailored by body. Also, much lower melting temperature 
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(57oC) and glass transition temperature (-62oC) make it much easier to be processed 
for scaffolding (Lanza et al., 1997). Researches are being carried out in order to 
optimize PCL scaffolds. 
2.3.2. Poly(N-vinyl-2-pyrrolidone-co-maleic anhydride) as a potential scaffold 
precursor 
Poly(N-vinyl-2-pyrrolidone-co-maleic anhydride) (P(VP-co-MAN)) is the 
copolymerization product of N-vinyl-2-pyrrolidone (NVP) and maleic anhydride 
(MAN) and carries the non-toxic properties of its monomers. 
NVP is a fluid monomer at room temperature. It can mix with water and organic 
solvents at each rate. Thus, when exposed to air, the monomer gets moisture from the 
air easily. When contained in the structure of polymers, NVP gives hydrophilicity 
property to the polymers. Polyvinylpyrrolidone (PVP) is the product of the 
homopolymerization of NVP (2.2). Although NVP is a toxic monomer because of its 
double bond in vinyl group, the double bond converts to non-toxic, single bonds 
when polymerized. Thus, its polymers are not toxic (Ushakov et al., 2005).  
 
                                 
 
 
(2.2) 
 
Like NVP, PVP can dissolve in water and other polar organic solutions. Since it has 
high affinity to water, it gets moisture at very short time when exposed to air and 
forms film. Thus, it has high drying property and used at coatings. Because of its 
biocompability and high degree hydrophilicity, PVP is a biodegradable polymer used 
as a drug carrier at pharmaceutics (Sharma et al., 1996) and has metal binding ability 
(Tezcan, 2006b). Morever, PVP was used as blood plasma expander in world war 2 
(Ravin et al., 1952). 
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MAN is an active reagent and can give copolymerization reaction with vinyl 
alcohols, vinyl esters, vinyl halogens, vinyl ketones acrylic acids, acrylic and 
metacrylic esters, acrylic amides, and acrylonitriles (2.3).  
 
    
 
     (2.3) 
 
MAN makes charge transfer complex (CTC) with NVP in the copolmerization 
reaction (2.4) (Georgiev et al., 1992). 
 
           (2.4) 
 
Because of its repeating maleic anhydride units, P(VP-co-MAN) has high reactivity. 
P(VP-co-MAN) is a type of polyanhydrides and can give the reactions of 
polyanhydrides. Anhydrides are very reactive groups so that an organic group (such 
as a drug or peptide) or inorganic group (metals) can be conjugated to 
polyanhydrides. MAN groups of P(VP-co-MAN) can bind chemical compounds by 
amidation and esterification reactions and can release the bonded group by 
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hydrolysis. Thus, P(VP-co-MAN) is a suitable polymer for drug delivery as like 
other  maleic anhydride polymers (Chitanu et al., 2002). 
Like the other anhydrides, the anhydride group of P(VP-co-MAN) can give 
esterification reactions with alcohols (2.5) and amidation reactions with amines (2.6) 
at the presence of acid catalysts. 
 
 
     (2.5) 
 
 
 
   (2.6) 
 
Conjugating the drugs makes it possible to direct the drug to target region in the 
body. Once the polymer-drug system reaches to an acidic or basic aqueous site in the 
body, it releases the alcohol based (2.7) or amine based (2.8) drug by hydrolysis 
(Bruice, 2004). 
 
 
 
  (2.7) 
 
 
 
          (2.8) 
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Also, hydrolysis causes ester and amid groups to convert to dicarboxylic acids which 
are much more hydrophilic and has higher tendency to be biodegraded (Linehan, 
1978). 
If the target compound don’t have an amine or alcohol group, then it can be 
conjugated to P(VP-co-MAN) with a spacer group containing amine or alcohol 
groups. Velty et al. galactosylated P(VP-co-MAN) with a amine spacer (1,4-diamino 
butane) in 2002 (Figure 2.4). 
 
 
Figure 2.4 : Galactosylation of P(VP-co-MAN) with Spacer Groups 
 
P(VP-co-MAN) has ability to bind chemical compounds with or without spacer 
groups. Thus, many drugs (Azori, 1986; Azori, 1988), sugars (Velty et al., 2002), 
peptides (Laure et al., 2001), proteins (Veron et al., 2001) and enzymes (Qian et al., 
1997) have already been coupled through anhydride group of P(VP-co-MAN). 
P(VP-co-MAN) hydrolyzes in water to give poly(N-vinyl -2-pyrrolidone-co-maleic 
acid) (P(VP-co-MA)) which is highly soluble in water (Temiz, et al., 2006) (2.9).  
 
 
 
(2.9) 
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Because of having amid group, P(VP-co-MA) is a potential target of peptidases like 
do in PVP. Also, P(VP-co-MA) has carboxylic acids groups coming from maleic 
acid units. The maleic acid units increases the biodegradation possibility of 
P(VP-co-MA) because carboxylic acid groups are potential targets of catalytic 
enzymes β-oxidation pathway. Thus, P(VP-co-MA) is probably biodegradable like 
polymaleic acid (Katti et al., 2002; Linehan, 1978). Moreover, metal binding 
property of P(VP-co-MA) (Tezcan, 2006b) makes it possible to bind to 
hydroxyapatite and construct a biodegradable composite. 
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3. EXPERIMENTAL PART 
3.1. Materials 
1M NaOH Solution : 4 g NaOH from Riedel-de Haen was diluted to 100 ml with distilled water. 
1M CaCl2.2H2O Solution 
: 147 g CaCl2.2H2O from Merck was dilluted to 1L 
with distilled water. Kept at the room temperature 
1M NaH2PO4.2H2O 
Solution 
: 156 g NaH2PO4.2H2O from Merck was dilluted to 1L 
with distilled water. Stored at the room temperature 
Acetone  : Riedel-de Haen 
Azobis(isobutyronitrile) : AIBN, Merck 
Benzoyl peroxide  : BPO, Fluka 
Diethyl Ether : Carlo Erba 
Deuterium Oxide  : D2O, Merck 
Hydroxyapatite,  
: Synthetic hydroxyapatite (Hass) produced from 
seashells was used only for FT-IR spectrums, not at 
the composite production. 
KBr : Merck 
Ketamine hydrochloride : Sigma 
Maleic Anhydride : Sigma.  
N-Vinyl-2-Pyrrolidone : Merck 
Polyvinylpyrrolidone : Carlo Erba. Fw:25000-30000 
Rats 
: Copenhagen rats with weights of 130 -170 g were 
supplied from Şişli Etfal Education and Research 
Hospital 
Toluene : Merck. Water was removed by adding sodium wire 
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3.2. Instruments 
Balance : Precisa XB 220A, Petit Balan and Sauter 
Centrifuges 
: Beckman Coulter, Allegro 25R Centrifuge 
: Beckman Coulter,  Avanti TM J-30 I 
: Beckman Coulter: Microfuge 18 Centrifuge 
Fluorescence 
Microscopy : BX60 Olympus Corporation 
Fluorescence 
Spectroscopy 
: Shimadzu RF-5301. Purified dry samples were 
spreaded onto lamels as a thin layer and investigated 
under WIB filter (excitation : 460-490 nm, 
emission : 515 nm) and 1000x magnification. 
FT-IR : Infrared spectra were recorded on disks of %1 w/w 
samples/KBr mixtures by Perkin Elmer spectrum one. 
Magnetic Stirrer                : AGE 10.0164, VELP Scientifica srl. 
Nuclear Magnetic 
Resonance (NMR) 
 : 1HNMR and 13C analysis's were recorded in D2O by 
250 MHz Bruker AC300 
pH Meter : InoLab pH720 
Vacuum  : Shel-LAB, H10 
X Ray Diffractometer 
(XRD) 
: Philips PW1710. The slush samples were spreaded 
onto lamels as thin layers and the system was operated 
at 45 kV, 40 mA and 2θ = 10-80o , step size of 0.05 
and exposure time of 2 s. 
3.3. Synthesis of Poly(N-Vinyl-2-Pyrrolidone-co-Maleic Acid) 
A 250 ml round-bottomed three necked flask covered with aluminum foil was 
equipped with a magnetic stirrer, a reflux condenser with CaCl2 tube and a 
thermometer. Then, 60 ml toluene was added and nitrogen gases were given to the 
system slowly. The system was plunged into oil bath whose temperature had been 
formerly set to 77oC (Figure 3.1.). The temperature of the system has been monitored 
by the thermometer. While stirring with magnetic stirrer, 10.1 g maleic anhydride 
was added and in order to solubilize the maleic anhydride, the mixture was stirred for 
10 min at 77oC. Then, 10 ml vinylpyrrolidone was added to the system. After charge 
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transfer complex formation, 0.2 g AIBN or 0.3g BPO were added to initiate the 
polymerization reaction. Reaction has been continued for two hours.  
 
 
Figure 3.1 : Synthesis System of P(VP-co-MAN) 
 
The copolymer precipitated out of toluene solution during the course of 
polymerization. After 2 hours of reaction, the reaction mixture was centrufuged at 
3000 rpm for 2 min. and the precipitated product was washed several times with 
diethyl ether and dried in vacuum at 60oC for 2 days. The product was dissolved in 
distilled water to obtain 50 mg/ml poly(N-vinyl-2-pyrrolidone-co-maleic-acid) stock 
solution. 2 ml of stock P(VP-co-MA) solution was added to 20 ml acetone. After 
centrifugation at 4000 rpm for 2 min, the precipitate was washed with distilled water 
3 times and then the precipitate was dried at 80 oC for 2 days. 
3.4. Synthesis of Composites 
Composite synthesis was performed in three steps. First of all, hydroxyapatite was 
synthesized through wet chemical synthesis method. Then, blank (control) 
experiments were carried out by crosslinking hydroxyapatite with PVP. Finally, 
hydroxyapatite was crosslinked with P(VP-co-MA). Crosslinking processes were 
done by in situ HA synthesis over the polymers or conjugation the polymers with ex 
situ synthesized hydroxyapatite. 
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3.4.1. Synthesis of hydroxyapatite 
Hydroxyapatite was synthesized by wet chemical synthesis method (Macipe et al., 
1998). While holding pH at 7.4 with 2.5 M NaOH solution, 1M NaH2PO4 solution 
was added slowly into 1M CaCl2 solution at a Ca/P mole ratio of 5/3 at room 
temperature in a flask. Then, the system was transferred to a three-necked flask and 
while stirring vigorously, the reaction was continued at 70oC under nitrogen 
atmosphere overnight. Then, the mixture was transferred to a flask and centrifuged at 
3000 rpm for 2 min. after pH was set to 7.4. Later, the pellet was washed 3 times 
with distilled water and HA slush was obtained. HA synthesized by this method was 
named as HAw. 
3.4.2. Blank experiments 
PVP/HA composites were synthesized with two methods: Synthesis of HA over PVP 
and conjugation of PVP with ex situ prepared HA. 
3.4.2.1. In situ HA synthesis over PVP 
50 mg/ml stock PVP solution in distilled water was stirred with 1M CaCl2 solution at 
room temperature at pH 7.4 for 5 min. Then, 1M NaH2PO4 solution was added 
slowly at a Ca/P mole ratio of 5/3, while the pH was held constant by 1M NaOH 
solution. The solution was mixed with magnetic stirrer in room temperature 
overnight; pH was maintained with 1M NaOH solution. The solutions were 
centrifuged at 25000 rcf for 5 min.  
In order to purify the resulted composite from non-reacted reactants and side 
products, the pellets were dispersed in water and centrifuged at 25000 rcf for 5 min 
again. This step was repeated for 3 times. Then, the pellets in slush form were hold at 
room temperature up to usage. 
4 composites were prepared at PVP/HA weight ratios of 1/10, 1/5, 1/2 and 1/1. The 
composites were named as follows: 1/10 PVP/iHA, 1/5 PVPiHA, 1/2iHA/PVP, and 
1/1 PVP/iHA. 
3.4.2.2. Conjugation of PVP with ex situ prepared HA 
Hydroxyapatite slush was dispersed in distilled water and 50 mg/ml PVP solution 
was added slowly while stirring the solution vigorously at room temperature. The 
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reaction continued at room temperature overnight. The pH was held constant at 7.4 
by 1M NaOH solution. The solutions were centrifuged at 25000 rcf for 5 min.  
In order to purify the resulted composite from non-reacted reactants and side 
products, the pellets were dispersed in water and centrifuged at 25000 rcf for 5 min 
again. This step was repeated for 3 times. Then, the pellets in slush form were hold at 
room temperature up to usage. 
4 composites were prepared at PVP/HA weight ratios of 1/10, 1/5, 1/2 and 1/1. The 
composites are named as follows: 10/1 PVP/eHA, 1/5 PVP/eHA, 1/2 PVP/eHA and 
1/1 PVP/eHA.  
3.4.3. Synthesis of P(VP-co-MA)/HA composites 
HA/P(VP-co-MA) composites were synthesized with two methods: Synthesis of HA 
over P(VP-co-MA) and conjugation of P(VP-co-MA) with ex situ prepared HA. 
3.4.3.1. In situ HA synthesis over P(VP-co-MA) 
50 mg/ml stock P(VP-co-MA) solution in distilled water was stirred with 1M CaCl2 
solution at room temperature at pH 7.4 for 5 min. Then, 1M NaH2PO4 solution was 
added slowly at a Ca/P mole ratio of 5/3, while the pH was held constant by 
1M NaOH solution. The solution was mixed vigorously in room temperature 
overnight while pH was maintained at 7.4 with 1M NaOH solution. The solutions 
were centrifuged at 25000 rcf for 5 min.  
In order to purify the resulted composite from non-reacted reactants and side 
products, the pellets were dispersed in water and centrifuged at 25000 rcf for 5 min 
again. This step was repeated for 3 times. Then, the pellets in slush form were hold at 
room temperature up to usage. 
6 composites were prepared at P(VP-co-MA)/HA weight ratios of 1/100, 1/10, 1/5, 
1/3, 1/2 and 1/1. The composites were named as follows: 1/100i P(VP-co-MA)/iHA, 
1/10 P(VP-co-MA)/iHA, 1/5 P(VP-co-MA)/iHA, 1/3 P(VP-co-MA)/iHA, 1/2 P(VP-
co-MA)/iHA, and 1/1P(VP-co-MA)/iHA. 
3.4.3.2. Conjugation of P(VP-co-MA) with ex situ prepared HA 
Hydroxyapatite slush was dispersed in distilled water and 50 mg/ml P(VP-co-MAN) 
solution was added slowly while stirring the solution vigorously at room 
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temperature. The reaction continued at room temperature overnight. The pH was held 
constant at 7.4 by 1M NaOH solution. The solutions were centrifuged at 25000 rcf 
for 5 min.  
In order to purify the resulted composite from non-reacted reactants and side 
products, the pellets were dispersed in water and centrifuged at 25000 rcf for 5 min 
again. This step was repeated for 3 times. Then, the pellets in slush form were hold at 
room temperature up to usage. 
4 composites were prepared at P(VP-co-MA)/HA weight ratios of 1/10, 1/5, 1/2 and 
1/1. The composites were named as follows: 1/10 P(VP-co-MA)/eHA, 1/5 P(VP-co-
MA)/ eHA, 1/2/P(VP-co-MA) /eHA, and 1/1P(VP-co-MA)/eHA. 
3.5. Scaffolding 
3.5.1. Scaffolding with gas foaming/particulate leaching method 
The slush composites were dried at 80 oC overnight and were grinded. Then, the dry 
composites were mixed with grinded NaCl at several ratios. Distilled water was 
added to solid mixtures with 7% weight ratio. Then, they were loaded into stainless 
steel mould and 7000 psi pressure was applied to make cylindrical scaffolds with 
1.25 cm diameter and 0.5 cm height. Later, the pellets were dried at 70oC at vacuum 
for 30 min. The dry pellets were immersed in distilled water for one day and the 
porous pellets are removed from distilled water and dried at 80oC for 2 hours. 
3.5.2. Scaffolding with wet molding 
3.5.2.1. Scaffolding with solvent casting/particulate leaching 
The slush composites were dispersed in distilled water to form 20 mg/ml to 
200 mg/ml milky solutions. NaCl was added into milky solution at NaCl/composite 
weight ratios from 3/1 to 0. Then, 750 µl of milky solutions were poured into teflon 
molds and let to dry at several temperatures to form cylindrical scaffolds. The 
scaffolds were put into distilled water to remove NaCl particles and form pores. The 
porous scaffolds were dried at 70oC for 2 hours. 
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3.5.2.2. Scaffolding with slush molding/particulate leaching 
400-500 mg wet solid particles were crushed and mixed with grinded 30 mg to 
500 mg NaCl particles. The wet solid mixture was loaded into teflon cylinder to 
make 0.5 cm x 1 cm cylindrical scaffolds or into a syringe to make 0.1 cm x 1 cm 
cylindrical scaffolds (Figure 3.2). Then, they were pressed to form cylindrical wet 
scaffolds. The wet scaffolds were dried at 37oC and put into distilled water to remove 
NaCl particles and form pores. 
 
 
Figure 3.2 : Slush Molding with a, b: Teflon Cylinder and c: Syringe 
 
3.6. Transplantation of Scaffolds to Rat Femur 
Transplantation operations were carried out at Şişli Etfal Education and Research 
Hospital, Microsurgery Education Development and Research Center in Istanbul by 
Dr. Gürsel Turgut and Dr. Nebil Yeşiloğlu in the management of Prof. Dr. Lütfü Baş. 
Scaffolds made of four samples were as follows: Synthetic hydroxyapatite, 
1/5eHA/P(VP-co-MA), 1/2/eHA/P(VP-co-MA) and 1/1eHA/P(VP-co-MA) were 
used for transplantation experiments. Also, no sample was transplanted to one group 
as the control group. Each group contained seven Copenhagen rats. 
3.6.1. Surgical procedure 
Firstly, prophylasis were maintained by single dose injection of 1 ampicillin. Then, 
the rats were anesthesized with ketamine (50 mg/kg). Then, left femur medial surface 
was scratched at anterior position to make a vertical 2 mm x 1 cm cylindrical hole 
(Figure 3.3).  
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Figure 3.3 : Cylindrical holes were opened at femur 
  
Then, composites with the same shape of the cylindrical hole were transplanted to 
the hole (Figure 3.4.). No sample was transplanted to the control group. 
 
Figure 3.4 : Transplantation to the holes 
 
3.6.2. Post-surgical maintenance 
After the surgery, 1 ml ampicillin and 0.5 ml metamizole were injected for 
prophylaxis and analgesia. Rats were transferred to cages with two rats in each cage 
and feed at 22 oC under 12 hour light/12 hour dark cycles.  
3.6.3. Histological investigation 
The study is on the post surgical maintenance step now. Histological investigations 
will be done in September 2008. The rats will be killed with high dose of ketamine 
injection and left femurs of the rats will be ejected and vascularity, biocompability 
and fibroblast infiltration tests will be done. 
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4. RESULTS AND DISCUSSION 
Hydroxyapatite was crosslinked with P(VP-co-MA) in order to make biocompatible, 
biodegradable, osteoinductive and osteoconductive scaffolds with high 
osteointegration properties. Crosslinking of hydroxyapatite was also carried out by 
PVP in order to understand the mechanism of chemical reaction between 
P(VP-co-MA) and hydroxyapatite. 
P(VP-co-MA) polymer was used because it has many properties:  
First of all, it is biodegradable, soluble in water and highly hydrophilic. Thus, it was 
not necessary to use toxic organic solvents to solve the polymer in the composite 
synthesis reaction. Furthermore, high hydrophilicity of the polymer may allow cells 
to attach scaffolds earlier. Thus, it can solve osteointegration problems of some 
implants.  
Secondly, due to the presence of many electrophilic groups, P(VP-co-MA) chealates 
with metals (Tezcan, 2006b). Thus, it may also chelate with calcium ions found at 
hydroxyapatite or initiate hydroxyapatite formation in presence of calcium and 
phosphor ions. Also, this project can be expanded by bonding some metals used in 
bone implants such as titanium. 
Thirdly, P(VP-co-MA) has significant anti-inflammatory effect (Azori, 1988). This 
property decreases the risk of host rejection of the scaffold significantly. 
Fourthly, P(VP-co-MA) is produced in anhydride form (P(VP-co-MAN)) which is 
very reactive polymer. Thus, some drugs (Azori, 1986; Azori, 1988), sugars (Velty et 
al., 2002), peptides (Laure et al., 2001), proteins (Veron et al., 2001) and enzymes 
(Qian et al., 1997) have been coupled to this polymer. The polymer releases the 
coupled compound slowly in water. Thus, it allows us to conjugate many things such 
as growth factors, for bone tissue engineering and release them slowly. 
Finally, P(VP-co-MA) is known to be fluorescencing (Tezcan, 2006a). This property 
may lead to produce fluorescencing composites.
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4.1. Synthesis and Characterization of P(VP-co-MAN) 
VP and MAN produces alternating copolymer, P(VP-co-MAN) (4.1). 
 
     
(4.1) 
 
At the copolymerization reaction, all the reactants and solvents must be pure because 
impurities directly affect the quality and yield of product. Since water prevents 
charge transfer complex formation, the reaction environment must be water free. In 
order to remove water, sodium wire was added into the solvent (toluene). After the 
mixture of NVP and MAN in toluene heated to 77oC, the solution turned to pink-red 
colour indicating the charge transfer complex formation (4.2).  
 
                          (4.2) 
 
After the CTC formation, free radical initiator (AIBN or BPO) was added at 77oC. 
Reaction was continued for 2 hours. At the end of the reaction, the product was 
obtained with 77% yield. In radical polymerizations, reaction time affects the yield, 
so higher yield could be obtained if the reaction time was longer. 
After the synthesis, purification and washing, characterizations of the product were 
made. First of all, FT-IR spectrum of PVP (Figure 4.1) was examined to compare 
with FT-IR spectrum of synthesized product. 
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Figure 4.1 : FT-IR spectrum of PVP 
 
Figure 4.1 shows FT-IR spectrum of PVP taken from KBr pellet. There are peaks of 
aliphatic C-H stretches at 2924 cm-1 and 2955 cm-1, lactam C=O stretches at 
1668 cm-1 and C-N stretches at 1224 and 1288 cm-1. These peaks were compared 
with the peaks of P(VP-co-MAN) (Figure 4.2). 
 
 
Figure 4.2 : FT-IR spectrum of P(VP-co-MAN) 
 
When the spectra of PVP (Figure 4.1) and P(VP-co-MAN) (Figure 4.2) are 
compared, both of them have peaks at around 2924 cm-1 which indicates aliphatic 
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C-H stretches of NVP. As seen in figure 4.2, lactam C=O stretches of 
P(VP-co-MAN) shifted from 1668 cm-1 to 1674 cm-1. There is a lactam C-N peak at 
1374 cm-1. Also, presence of anhydride carbonyl peaks at 1849 cm-1 and 1781 cm-1, 
and cyclic C-O-C peaks 933-1090 cm-1 indicates that the copolymerization reaction 
was achieved successfully because and the product has the characteristic peaks 
coming from both NVP and MAN. 
Also, FT-IR spectrum of P(VP-co-MA), hydrolyzed form of P(VP-co-MAN), was 
taken (Figure 4.3). 
  
 
Figure 4.3 : FT-IR spectrum of P(VP-co-MA) 
 
As seen in figure 4.3, P(VP-co-MA) lacks anhydride carbonyl peaks at 1849 cm-1 and 
1781 cm-1 whereas it has additional carboxylic acid carbonyl peaks at about 1704. 
This situation shows the hydrolysis of anhydride groups to give carboxylic acid 
groups at P(VP-co-MA). 
Further characterization was made by 1H NMR spectrum of the product (Figure 4.4). 
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Figure 4.4 : 1H NMR spectrum of P(VP-co-MAN) 
 
Figure 4.5 shows protons of repeating units and table 4.1 shows the estimations for 
the peaks of protons of P(VP-co-MAN) according to figure 4.5. 
 
Figure 4.5 : Protons of Repeating Units of P(VP-co-MAN) 
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Table 4.1 : Estimated chemical shifts of shown protons shown at figure 3.4. 
Protons Ha Hb Hc Hd He Hf Hg 
Chemical Shift 
δ (ppm) 
1.92-
2.02 
2.07-
2.27 2.15~ 
2.16-
2.26 
3.3-
3.4 3.12 4.4 
 
Also, we measured fluorescence of P(VP-co-MA). The optimum excitation and 
emission wavelength of 20 mg/ml P(VP-co-MA) solution in water was measured 
with search λ function of RF-5301 program and found as 331 nm for excitation and 
441 nm for emission. Then, fluorescence of P(VP-co-MA) was measured at 331 nm 
excitation and 441 nm emission at several concentrations (table 4.2) to make a 
calibration curve (Figure 4.6).  
Table 4.2 : Emission values of several aqueous P(VP-co-MA) solutions at excitation 331 
nm, emission 441 nm. 
Concentration 
(ppm) 0 6.25 12.5 25 50 100 156.25 250 312.5 
Emission 2378 3309 5620 5735 7937 11905 16412 22579 29607 
 
 
Figure 4.6 : Calibration Curve for Fluorescence of P(VP-co-MA) 
 
As seen in figure 4.6, fluorescence of P(VP-co-MA) follows a linear curve from 6 
ppm to 300 ppm in water. In the other words, its quantity can easily and accurately 
be detected within this concentration interval. 
Finally, the image of P(VP-co-MA) gel was taken under light and fluorescence 
microscopy at 1000x magnification (Figure 4.7).       
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Figure 4.7 : Image of P(VP-co-MA) gel under light and fluorescence microscopy 
 
As seen in figure 4.7, fluorescence of P(VP-co-MA) can easily be observed under 
fluorescence microscopy with WIB filter (excitation : 460-490 nm, emission : 515 
nm). 
As result, synthesis of P(VP-co-MAN) and P(VP-co-MA) were confirmed with 
FT-IR spectrum and NMR spectra, and fluorescence spectroscopy. Also, as seen in 
figure 4.6 and figure 4.7, P(VP-co-MA) makes fluorescence that is detectable even at 
very low concentrations (6 ppm). This property may lead to produce fluorescencing 
composites. 
4.2. Synthesis of Composites 
Composite synthesis was performed in three steps. First of all, hydroxyapatite was 
synthesized through wet chemical synthesis method. Then, blank (control) 
experiments were carried out by crosslinking hydroxyapatite with PVP. Finally, 
hydroxyapatite was crosslinked with P(VP-co-MA). Crosslinking processes were 
done by in situ HA synthesis over the polymers or conjugation the polymers with 
ex situ synthesized hydroxyapatite. 
4.2.1. Synthesis of hydroxyapatite 
Hydroxyapatite synthesis was carried out under nitrogen in order to remove carbon 
dioxide of the air. For FT-IR analysis, the synthesized HA was dried at 80oC for one 
day. Then, a FT-IR spectrum (Figure 4.8) was taken from 1% KBr tablets. 
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Figure 4.8 : FT-IR spectrum of hydroxyapatite 
 
As seen in figure 4.8, there are characteristic v2 phosphate bands at 566 cm-1 and 
601 cm-1, v1 phosphate band at 954 cm-1 and v3 phosphate bands at 1087 cm-1 and 
1020 cm-1. These bands prove that the synthesis of hydroxyapatite was achieved 
successfully. The broadest band between 3000 cm-1 and 3700 cm-1 is due to residual 
water (Peon et al, 2004). 
4.2.2. Blank experiments 
PVP is homopolymer of vinylpyrrolidone, one of monomeric units of P(VP-co-MA). 
Also it is very cheap and can be obtained easily. Thus, PVP/HA composites were 
prepared as control in order to understand the binding mechanism of P(VP-co-MA) 
to HA.  
4.2.2.1. In situ HA synthesis over PVP 
Biomineralization process was tried to be mimicked by synthesizing HA over PVP 
(Figure 4.9) as we did with P(VP-co-MA).  
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Figure 4.9 : FT-IR spectrum of in situ synthesized PVP/iHA composites 
 
As seen in figure 4.9, there are not significant PVP peaks at the 1/1 PVP/iHA 
composite. Only, there are PO43- vibration peaks at about 1020 cm-1 coming from 
HA. Thus, 1/1 PVP/iHA looks like free HA more than composite. 
PVP peaks can be seen at very low intensity at the 1/2 PVP/iHA composite. There is 
a visible peak of aliphatic C-H stretches at around 2924 cm-1 and carbonyl peaks at 
around 1570 cm-1. However, PO43- vibration peaks (coming from HA) at about 
1020 cm-1 are much more intense than peaks of PVP. Thus, it seems that PVP 
doesn’t initiate HA growth over itself. HA growth occurred unconnected to PVP and 
so that isolated product is almost free from PVP. 
4.2.2.2. Conjugation of PVP with ex situ prepared HA  
In this step, firstly, hydroxyapatite was synthesized free from PVP and then 
conjugated with PVP. In order to analyze the conjugation, FT-IR spectra of products 
were taken (Figure 4.10). 
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Figure 4.10 : FT-IR spectra of ex situ prepared PVP/HA composites 
 
PVP/HA composites synthesized with reaction of ex situ synthesized HA have much 
more significant peaks belonging to PVP than in situ synthesized composites. All the 
composites have PO43- vibration peaks at about 1037 cm-1 coming from HA. Also all 
the composites have C-H stretch peaks at around 2924 cm-1 and carbonyl peaks at 
around 1662 cm-1 coming from PVP.  
As result, chemical reaction between PVP and hydroxyapatite was observed only at 
ex situ synthesized composites. PVP seems not to be initiating hydroxyapatite growth 
over itself, but it is able to bind ex situ synthesized hydroxyapatite. 
4.2.3. Synthesis of P(VP-co-MA)/HA composites 
P(VP-co-MA)/HA composites were synthesized in the same way with done with 
PVP. 
4.2.3.1. In situ HA synthesis over P(VP-co-MAN) 
Biomineralization process was tried to be mimicked by synthesizing hydroxyapatite 
over P(VP-co-MA). The chemical synthesis reactions were confirmed with FT-IR 
spectra (Figure 4.11).  
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Figure 4.11 : FT-IR Spectra of in situ prepared P(VP-co-MA)/iHA composites 
 
As seen in figure 4.11, composites have characteristic bands of both P(VP-co-MA) 
and HA. Also, there are shifts at the bands. The greatest shift was seen in carbonyl 
peaks. Carbonyl peaks of P(VP-co-MA) shifted from 1704 cm-1 to about 1581 cm-1. 
This shift proves that free carboxylic acids of maleic acid group were converted to 
calcium carboxylate groups (Kato et al., 1997). 
The polymeric bands of composites cannot be from free P(VP-co-MA) because all 
the composite synthesis reaction was carried out in water and the composites were 
precipitated by centrifugation. Free P(VP-co-MA) is highly soluble in water and 
doesn’t precipitate by centrifugation from water. Also, the precipitates were washed 
three times. Thus, highly water soluble, free polymer must be removed at these steps. 
P(VP-co-MA)/iHA composites were compared with PVP/iHA composites from the 
FT-IR spectra (Figure 4.12). 
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Figure 4.12 : Comparision of PVP/iHA and P(VP-co-MA)/iHA composites 
 
Both P(VP-co-MA) and PVP have lactam carbonyls to conjugate with 
hydroxyapatite. In the figure 4.14, the chemical shifts of P(VP-co-MA) carbonyls are 
much more than these of PVP carbonyls. These shifts are the result of hydrogen 
bonds and reactions of carbonyls with calcium ion of hydroxyapatite. Both, 
P(VP-co-MA)/iHA and PVP/iHA have phosphate peaks coming from hydroxyapatite 
but there is more branching at the 1/2 PVP/iHA composite. This situation shows that 
PVP makes many hydrogen bonds with phosphate groups and calcium ions of 
hydroxyapatite. The hydrogen bonds seem to be more dominant at the PVP/iHA 
composites than chemical reactions. However, P(VP-co-MA) makes chemical 
reaction from its carboxyl groups with calcium ions of hydroxyapatite and the 
chemical reaction is more dominant at the P(VP-co-MA)/iHA composites. 
As result, we can say that the interactions of P(VP-co-MA) with hydroxyapatite is 
based on chemical reactions while those of PVP with hydroxyapatite is based on 
hydrogen bonds. 
Then, crystallinity of the P(VP-co-MA)iHA composites was investigated with XRD 
(Figure 4.13). 
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Figure 4.13 : XRD Spectra of P(VP-co-MAN), HA and composites 
 
Hydroxyapatite has characteristic bands indicating its crystallinity between 30o and 
45o (Peon, et al. 2004). XRD spectra of HAw (produced by wet chemical synthesis 
method) are very close to that of HAss (synthetic HA produced from seashells). 
However, HAss is a bit more crystalline than HAw because HAss has sharper bands. 
It is obvious that free polymer is much amorphous than hydroxyapatite because the 
band of free polymer is much broader and 2θ degree is much lower than 2θ degree of 
HA bands. However, much sharper peaks of composites indicate that they are much 
more crystalline than free P(VP-co-MA), but when polymer content increases, peaks 
be slightly broader. In the other words, composites with higher polymer ratio are 
more amorphous, but crystallinity degree of them is much higher than that of free 
polymer. We can say that we synthesized hydroxyapatite over P(VP-co-MA) with 
close crystallinity to HA.  
4.2.3.2. Conjugation of P(VP-co-MAN) with ex situ prepared HA  
FT-IR spectra were taken for each sample over 1% KBr tablets (Figure 4.14). 
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Figure 4.14 : FT-IR Spectra of ex situ prepared P(VP-co-MA)/eHA composites 
 
Like in situ HA synthesis over P(VP-co-MA), ex situ composites have both 
characteristic polymeric bands and HA bands. The peaks at about 1581 cm-1 indicate 
a typical carboxylate-calcium bond (Kato et al., 1997). Thus, we can say that P(VP-
co-MA) binds to calcium of HA over its carboxyl groups like do in the in situ 
synthesized composites. 
In order to understand crystallinity of the ex situ synthesized composites, XRD 
spectra of the composites were taken (Figure 4.15). 
 
Figure 4.15 : XRD spectrum of ex situ prepared composites 
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As seen in figure 4.15, the crystallinity of HAss is almost the same with that of the 
composites. We suggest that the reason of this situation is addition of P(VP-co-MA) 
after the formation of HA crystals. Here, P(VP-co-MA) only crosslinked HA, didn’t 
affect its crystallinity much. However, at the “in situ HA synthesis over P(VP-co-
MA)”  method, the crystal growth of hydroxyapatite was performed in the presence 
of the copolymer. Thus, at in situ synthesis method, the copolymer directly 
determined the crystallinity of HA.  
Finally, the images of ex situ synthesized composites were taken under fluorescence 
microscopy at WIB filter and 1000x magnification (Figure 4.16). 
1/1 P(VP-co-MA)/eHA 1/10 P(VP-co-MA)/eHA 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16 : Images of ex situ synthesized composites under light and 
fluorescence microscopy 
 
As seen in figure 4.16, ex situ synthesized composites make fluorescence (free 
hydroxyapatite doesn’t make fluorescence under these conditions). The fluorescence 
of the composites cannot be coming from non-bonded P(VP-co-MA) because we 
washed composites with distilled water three times that is enough to remove the non-
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bonded highly soluble polymer. Also, FT-IR spectra showed that there is a chemical 
reaction between HA and P(VP-co-MA). 
4.3. Scaffolding 
Since P(VP-co-MA) and PVP are highly soluble in water, we didn’t need to use 
organic solvents. Therefore, we tried scaffolding methods without organic solvents.  
4.3.1. Scaffolding with gas foaming/particulate leaching method 
All the samples of in situ synthesized P(VP-co-MA)iHA and PVP/iHA composites 
were disintegrated when soaked in water even the absence of porosity. However, 
scaffolds made of HAss, HAw and conjugation of polymers with ex situ HA 
synthesis weren’t disintegrated in water. 
First of all, needed water percent and NaCl content for sintering were researched 
with HAss (table 4.3). 
Table 4.3 : Optimizations of water content for sintering 
Sample WNaCl/WComposite %Wwater Disintegration? 
HAss 3/1 1 Yes 
HAss 3/1 2 Yes 
HAss 3/1 3 Yes 
HAss 3/1 7 No 
1/10 P(VP-co-MA)/eHA 2/1 7 Yes 
1/10 P(VP-co-MA)/eHA 1/1 7 No 
1/5 P(VP-co-MA)/eHA 1/1 7 No 
1/2 P(VP-co-MA)/eHA 1/1 7 No 
1/1 P(VP-co-MA)/eHA 1/1 7 No 
    
1/10 PVP/eHA 1/1 7 No 
1/5 PVP/eHA 1/1 7 No 
1/2 PVP/eHA 1/1 7 No 
1/1 PVP/eHA 1/1 7 No 
 
As seen in table 4.3, first of all we tried to optimize water content with HAss and 
found the optimum ratio as 7% at WComposite/WNaCl = 3/1. However, 
WComposite/WNaCl = 3/1 didn’t work on composites, so we decreased the 
WComposite/WNaCl ratio down to 1/1 which worked for all the composites.  
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However, the resulted composites were very fragile so they weren’t optimal for bone 
tissue engineering. Thus, we decreased the WComposite/WNaCl ratio firstly down to 1/5. 
Then, resulted composites were fragile again. Therefore, we tried without putting 
NaCl and the result was the same. Thus, we passed to other scaffolding methods.  
4.3.2. Scaffolding with wet molding 
Slush composites are in form of nanoparticles that have potential to fuse each other 
and strengthen the resulted scaffold. Solvent casting/particulate leaching and slush 
molding/particulate leaching approaches were tried. 
4.3.2.1. Scaffolding with solvent casting/particulate leaching 
Optimum composite concentration and optimum NaCl content were researched for 
HAw and ex situ synthesized compozites (table 4.4). 
Table 4.4 : Preparation conditions of ex situ synthesized scaffolds 
Sample 
Composite 
Conc. 
(mg/ml) 
NaCl
 
Conc. 
(mg/ml) 
Property of Scaffold 
HAw 20 0 5mm dia. x 1 mm cylinder, fragile 
HAw 30 0 5mm dia. x 1.5 mm cylinder, fragile 
HAw 40 0 5mm dia. x 2 mm cylinder, fragile 
HAw 100 0 5mm dia. x 5 mm cylinder, fragile 
HAw 150 0 5mm dia. x 7 mm cylinder, fragile 
HAw 200 0 5mm dia. x 10 mm cylinder, fragile 
    
1/10 
P(VP-co-MA)/eHA 20 0 Small shapeless pieces 
1/10 
P(VP-co-MA)/eHA 30 0 Small shapeless pieces 
1/10 
P(VP-co-MA)/eHA 40 0 Small shapeless pieces 
1/10 
P(VP-co-MA)/eHA 100 0 Small shapeless pieces 
1/10 
P(VP-co-MA)/eHA 150 0 Hollow cylinder, fragile 
1/10 
P(VP-co-MA)/eHA 200 0 Hollow cylinder, fragile 
    
1/5 
P(VP-co-MA)/eHA 150 0 Hollow cylinder, fragile 
1/5 
P(VP-co-MA)/eHA 200 0 Hollow cylinder, fragile 
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Synthetic hydroxyapatite formed more fragile scaffolds than composites. During the 
drying process, composite nanoparticles tend to fuse and attract each other so that 
hollow cylindrical scaffold forms. In order to prevent hollow hole, different drying 
temperatures were tried but the result was the same. The only way was to increase 
the concentration up to make slush. 
Then, in situ synthesized composites were processed to make scaffolds (table 4.5). 
Table 4.5 : Preparation conditions of in situ synthesized scaffolds 
Sample 
Composite 
Conc. 
(mg/ml) 
NaCl
 
Conc. 
(mg/ml) 
Property of Scaffold 
1/5 
P(VP-co-MA)/iHA 150 0 5mm dia. x 7 mm cylinder, strong 
1/5 
P(VP-co-MA)/iHA 200 0 5mm dia. x 10 mm cylinder, strong 
 
   
1/5 
P(VP-co-MA)/iHA 150 50 5mm dia. x 10 mm cylinder, fragile 
1/5 
P(VP-co-MA)/iHA 200 50 5mm dia. x 12 mm cylinder, fragile 
    
1/2 
P(VP-co-MA)/iHA 150 50 5mm dia. x 10 mm cylinder, fragile 
1/2 
P(VP-co-MA)/iHA 200 50 5mm dia. x 12 mm cylinder, fragile 
 
Stronger composites were obtained but they disintegrated in water even if no NaCl 
was added.  Another problem was non-homogeneous water evaporation because of 
existence of only one side at the mould to let water evaporate (Figure 4.17). Thus, we 
passed to slush molding/particulate leaching method. 
 
Figure 4.17 : Teflon mould for solvent casting/particulate leaching method 
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4.3.2.2. Scaffolding with slush molding/particulate leaching 
Very strong scaffolds were obtained with this method. Also, since the slush was not 
fluid, the shaped slush can be removed from mould and then let to dry. Therefore, 
water can evaporate from each side of the scaffold, not only from open hole of the 
mould. Thus, more homogeneous scaffolds can be obtained. 
The resulted scaffolds are quite strong and don’t disintegrate in water. Also, because 
of high hydrophilicity, they emit water and can able to degrade slowly under attrition 
force. In the other words, it will degrade when bone cells reproduce and apply 
attrition force on it. 
4.4. Transplantation of Scaffolds to Rat Femur 
4.4.1. Surgical procedure 
Scaffolds emit water as soon as being exposed to water. In the same way, we suggest 
that it will emit blood so that it will allow matter exchange in vivo. Also, it will 
represent a hydrophilic contact area to bone cells which is very important property 
for osteointegration.  
Because of emitting water, the scaffolds become weak against attrition force and 
high pressure. Thus, femur wasn’t removed completely. It was scratched to make a 
hole and scaffolds were transplanted to the hole which doesn’t expose pressure of the 
body. We will investigate the effect of the polymeric samples on the healing rate and 
compare the results with synthetic hydroxyapatite, control group and other scaffolds 
in literature. 
4.4.2. Post-Surgical Maintenance 
The rats are being maintained under 12 hour light/12 hour dark cycles at 22 oC. We 
are now on this step. Experiments are being continued. 
4.4.3. Histological Investigations 
Histological investigations will be done after the post surgical maintenance step 
finishes. 
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5. CONCLUSION 
Poly(N-vinyl-2-pyrrolidone-co-maleic acid) was synthesized successfully. The 
synthesis was confirmed with FT-IR, NMR and fluorescence measurements. 
Polymeric constructs for tissue engineering were synthesized by crosslinking 
hydroxyapatite with poly(N-vinyl-2-pyrrolidone-co-maleic acid) and poly(N-vinyl-2-
pyrrolidone) in water. The produced composites were analyzed with FT-IR, XRD 
and fluorescence microscopy. 
The composites were processed to make scaffolds for bone tissue engineering 
without using organic solvents. Different methods were tried for scaffolding and wet 
molding method was adapted for the composites as slush molding method. 
Scaffolds were transplanted to femur bones of rats and bone healing is still being 
monitored. If transplantation experiments give good results, scaffolds will be tested 
with human osteoblast cell cultures and then with human patients. 
Next step will include crosslinking the scaffolds further with titanium in order to 
increase the mechanical properties of the scaffolds. 
 46   
REFERENCES 
Albrektsson, T. and Johansson, C., 2001. Osteoinduction, osteoconduction and 
osseointegration, C Eur Spine J  10, 96-101. 
Anderson, T.A., Tsao, R. and Coats, J.R., 1993. Journal of Environmental 
Polymer Degradation, 1, 301. 
Antranikian, G., 1992. in Microbial Degradation of Natural Products, Ed., G. 
Winkelmann, VCH, Weinheim, Germany, 27. 
Atala, A., Mooeny, D.J. et. al., 1997. Synthetic Biodegradable Polymer Scaffolds, 
Boston, MA: Birkhauser. 
Athanasiou, K.A.; Zhu, C.F.; Lanctot, D.R.; Agrawal, C.M. & Wang, X., 2000. 
Fundamentals of biomechanics in tissue engineering of bone, Tissue 
Engineering 6, 361-381. 
Azori, M., 1988. Polymeric Prodrug systems based on poly(N-vinylpyrrolidone-alt-
maleic anhydride), Poly. in Med. 3, 189-199. 
Azori, M., Pato, P., Fehervari, F., and Tudos, 1986. F. Polymeric Prodrugs, 4. In 
vitro study of the drug release on a model p-nitroanilide bound onto 
polyanionic carrier, Macromol. Chem. 187, 303-309. 
Baron, R., 2006. Anatomy and Ultrastructure of Bone, Departments of Orthopaedics 
and Cell Biology, Yale U., New Haven, Connecticut. 
Bessey O.A., Lowry O.H., Brock M.J., 1946. A method for the rapid determination 
of. alkaline phosphatase with five cubic mm of serum, J Biol Chem, 
164, 321-329. 
Biocolor Ltd, Sircol Soluble Collagen Assay, retrieved from 
http://www.biocolor.co.uk/sircol.html on May 2 2008, Belfast, N. 
Ireland. 
Bruice P.Y., 2004. Organic Chemistry (4th. Ed.), Prentice Hall, Inc. 
Chitanu, G.C., Bacu, E., Couture, A., Grandclaudon, P., Singurel, and 
G., Carpov, A., 2002. Potential drug delivery systems from maleic 
anhydride copolymers and phenothiazine derivatives, Eur. Poly. J., 38, 
1509-1513. 
Donaruma, L.G., Ottenbrite, R.M., Vogl, O. (Eds.)., 1980. Anionic polymeric 
drugs, John Wiley and Sons, New York. 
Engel, E., Michiardi, A., Navarro, M., Lacroix, D., and Planell, J.A., 2008. 
Nanotechnology in regenerative medicine: the materials side, Trends 
Biotechnol., 26, 39-47. 
Felthouse T.R., Burnett J.C., Horrell B., Mummey M.J. and Kuo Y.J., 2001. 
Maleic anhydride, maleic acid, and fumaric acid, Kirk-Othmer 
encyclopedia of chemical technology, 4th ed., 15, 1–58. 
 47   
 
Georgiev, G., Konstantinov, C., and Kaboivanov, V., 1992. Role of the Charge-
Transfer Complex during the Copolymerization of 
N-Vinylpyrrolidone and Maleic Anhydride, Makromolecules, 25, 
6301-6308. 
Hulth, A., 1989. Current concepts of fracture healing. Clin. Orthop. Rel. Res., 249, 
265-284. 
Kato, K., Eika, Y., and Ikada, Y., 1997. In situ hydroxyapatite crystallization for 
the formation of hydroxyapatite/polymer composites, J. Mat. Sci. 32, 
5533-5543. 
Katti, D.S., Lakshmi, S., Langer, R., Laurencin, C.T., 2002. Toxicity, 
biodegradation and elimination of polyanhydrides, Adv. Drug. Del. 
Rew., 54, 933-961. 
Lancer, R., and Vacanti, J.P., 1993. Tissue engineering, Science 260, 920–926. 
Lanza, R., Langer, R., and Chick, W.L., 1997. Principles of tissue engineering, 
R.G.Landes. Company 
Laure, A., Cheynet, V., Oriol, G., Veron, L., Merlier, F., Scremin, G., 
Mandrand, B., Delair, T., and Mallet, F., 2001. Mechanisms 
Leading to an Oriented Immobilization of Recombinant Proteins 
Derived from the P24 Capsid of HIV-1 onto Copolymers, 
Bioconjugate Chem. 12, 972-979. 
Laurencin, C.T., Ambrosio, M.A., Borden, M.D., Cooper, J.A., 1999. Tissue 
Engineering: Orthopaedic Application, In Annual Reviews of 
Biomedical Engineering. Yarmush, M. (ed.) Palo Alto, Annual 
Reviews, 19-46. 
Linehan, D.J., 1978. The uptake by plants of polymaleic acid: A polycarboxylic acid 
structurally related to those of soils, Plant and Soil, 50, 625-632. 
Lu, H.H., Kofron, M.D., El-Amin, S.F., Attawia, M.A., and Laurencin, C.T., 
2003. In vitro bone formation using muscle-derived cells: A new 
paradigm for bone tissue engineering, Biochemical and Biophysical 
Research Communications, 305, 882-889. 
Macipe, A.L., Clemente, L.L., Lopez, A.H., Arita, I., Garduno, M.V.G., Rivera, 
E., and Castano, M.V., 1998. Wet Chemical Synthesis of 
Hydroxyapatite Particles from Nonstoichiometric Solutions, J. Mat. 
Syn. Proc., 6, 21-26. 
Marks, S. C., Hermey, D. C., 1996. The structure and development of bone. 
Bilezikian, J. P. Raisz, L. G. Rodan, G. A. eds. Principles of Bone 
Biology, 3-14 Academic Press San Diego, CA. 
Micos, A.G., Temenoff, J.S., 2000. Formation of highly porous biodegradable 
scaffolds for tissue engineering, Elec. J. Biotec. 3, 114-119. 
Miles, A.M. et al., 1996. Methods in Enzymology 268, 105, Elsevier. 
Mosmann, T., 1983. Rapid Colorimetric Assay for Cellular Growth and Survival: 
Application to Proliferation and Cytotoxicity Assays, J. Immunol. 
Meth. 65, 55-63. 
 48   
 
Nelson, D. L. and Cox, M.M., 2005. Lehninger Principles of Biochemistry (4th Ed), 
New York: W. H. Freeman and Comp. 
Peón, E., Fuentes, G., Delgado, J.A., Morejon, L., Almirall, A., and García, R., 
2004. Preparation and characterization of porous blocks of synthetic 
hydroxyapatite, Lat. Am. Appl. Res. 34, 225-228. 
Qian G., Ma, J., Zhou, J., and He, B., 1997. Chemical modification of E. coli L-
asparaginase with poly(N-vinylpyrrolidone-co-maleic anhydride), 
Reac. Func. Poly. 32, 117-121.  
Ratledge, C., 1994. in Biochemistry of Microbial Degradation, Ed., C. Ratledge, 
Kluwer Academic Publishers, Dordrecht, The Netherlands, Chapter 4. 
Ravin, H.A., Seligman, A.M., and Fine, J., 1952. N. Engl. J. Med., 247, 921. 
Saito, N., et. al., 2005. Synthetic biodegradable polymers as drug delivery systems 
for bone morphogenetic proteins,  Adv.. Drug Delivery rev,  57, 
 1037-1048. 
Schirmer, A., Matz, C. and Jendrossek, D., 1995. Canadian Journal of 
Microbiology, 41, 170. 
Sharma, D., Chelvi, T.P., Kaur, J., Chakravorty, K., De, T.K., Maitra, A., 
Ralhan, R., 1996. Novel Taxol formulation: polyvinylpyrrolidone 
nanoparticle-encapsulated Taxol for drug delivery in cancer therapy, 
Oncol Res. 8, 281-286. 
Stevenson, S., 1999. Biology of bone grafts, Orthop. Clin. North Am. 30, 543–552. 
Temiz, A. Toğay, S.O., Şener, A. Güven, G., Rzaev, Z.M. O. Pişkin, E., 2006. 
Antimicrobial Poly(N-vinyl-2-pyrrolidone-alt-maleic anhydride)/ 
Poly(ethylene imine) Macrocomplexes, J. of App. Poly. Sci., 102, 
5841-5847. 
Tezcan, E., 2006a. Biodegradable polymeric scaffolds for bionanotechnological 
applications, Grad. Thesis, I.T.U. Science & Letters Fac., Istanbul. 
Tezcan, E., 2006b. Controlled release of metals from poly(n-vınyl-2-pyrrolıdone-co-
maleic anhydrıde), Grad. Thesis, I.T.U. Science & Letters Fac., 
Istanbul. 
Tsang, V.L., and Bhatia, S.N., 2004. Three-dimensional tissue fabrication, Adv. 
Drug Delivery Rev. 56, 1635– 1647. 
Ushakov, S.N., Davidenkova, V.V., and Lushchik, V.V., 2005. The synthesis of 
vinylpyrrolidone, Russian Chem. Bull., 10, 831-833. 
Velty, R.A., Cristea, M., and Rinaudo, M., 2002. Galactosylated 
N-Vinylpyrrolidone-Maleic Acid Copolymers: Synthesis, 
Characterization, and Interaction with Lectins, Biomacromolecules 3, 
998-1005. 
Veron, L., Revol, M., Mandrand, B., and Delaır, T., 2001. Synthesis and 
characterization of poly(N-vinyl pyrrolidone-alt-maleic anhydride): 
conjugation with bovine serum albumin, J. Appl. Pol. Sci. 81, 
3327-3337. 
 49   
 
Whitaker, J.R., 1994. Principles of Enzymology for the Food Sciences, 2nd Edition, 
Marcel Dekker Inc., New York, NY, USA. 
Whitney, P.J., Swaffield, C.H. and Graffam, A.J., 1993. International 
Biodeterioration and Biodegradation,  31, 179. 
Wilson, A. P., 2000. Cytotoxicity and Viability Assays in Animal Cell Culture: A 
Practical Approach (3rd ed.), Ed. Masters, J.R.W. Oxford University 
Press: oXford, Vol. 1. 
Yaszemski, M.J., Payne, R.G., Hayes, W.C., Langer, R. & Mikos, A.G., 1996. 
Evolution of bone transplantation: molecular, cellular, and tissue 
strategies to engineer human bone, Biomaterials 17, 175-185. 
Zee, M., 2005. Biodegradability of Polymers – Mechanisms and Evaluation 
Methods, in Handbook of Biodegradable Polymers, pp. 1-32, Ed. 
Bastioli, C., Rapra Tech., UK. 
 
 
 
 
 
 
 
 
 
 
 50   
CURRICULUM VITAE 
Erdem Tezcan was born in Istanbul, Turkey. He graduated from Bahçelievler High 
School in 2001. Then, he attended Molecular Biology and Genetic Major Program in 
2001 in Istanbul Technical University (I.T.U.). In 2002, he attended Chemistry 
Major Program with Double Major Program in I.T.U. He graduated both of the major 
programs with first degree honor in Chemistry Major Program in 2006. His 
graduation thesis of Chemistry Major program was “Controlled Release of Metals 
from Poly(N-vinyl-2-pyrrolidone-co-maleic anhydride)”, and graduation thesis of 
Molecular Biology and Genetics Major Program was “Biodegradable Polymeric 
Scaffolds for Bionanotechnological Applications”. He attended Molecular Biology 
and Genetics & Biotechnology Master Program in 2006 and worked on “Polymeric 
Scaffolds Towards Tissue Engineering”. Later, he went to Greece for Leanardo Da 
Vinci Project of “Tissue Culture Expert Education” Programme in 2007. He 
graduated his master program in 2008. His areas of interests are tissue engineering, 
drug delivery and plant tissue biotechnology. 
 
 
